DECONEX IR- guaifenesin and phenylephrine hcl tablet
Poly Pharmaceuticals, Inc.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------
Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other respiratory allergies:
Do not exceed recommended dosage.
A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache, consult a doctor.
Ask a doctor before use if you have
Ask a doctor before use if you are taking sedatives or tranquilizers.
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Adults and children 12 years of age and older: 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours.
Children age 6 to 12 years of age: 1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours or as directed by a doctor.
Children 6 years of age and younger: Consult a physician.
Tamper evident: do not use if tamper evident seal is broken or missing. Store at 15°-30°C (59°-86°F).
Deconex IR Tablets are a green, oval, scored tablet debossed POLY 716 on one side, plain on the other.
DECONEX IR
guaifenesin and phenylephrine hcl tablet |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
Labeler - Poly Pharmaceuticals, Inc. (198449894) |